Sanofi-Aventis Presentation on Flagyl

Marketing Presentation

Instructor: Dr. MAK Chishty

Group Members Nasir Ali – 20414 Suhail Ahmed - 20646

Introduction The company was incorporated in 1967 as

Hoechst Pakistan Limited. Manufacture of pharmaceuticals and specialty chemicals began in 1973. In 1977 the company went public and was listed on the Karachi Stock Exchange.

By virtue of several mergers, acquisitions and divestitures the company underwent several reincarnations over the years. Today, the company is sanofi-aventis Pakistan limited while the corporate identity is simply Sanofi.

VALUES At sanofi-aventis, our values define our ethics

and serve as the moral compass of the company. They are the DNA of the company and distinguish us from other companies.

Innovation Confidence Respect Solidarity Integrity

Flagyl® Review

Flagyl is use for the treatment of infections of anaerobic bacteria or are suspected to be the cause.

Flagyl is active against a wide range of pathogenic micro-organisms notably species of Bacteroides, Fusobacteria, Clostridia, Eubacteria, anaerobic cocci and Gardnerella

Vaginalis.

Flagyl® (Metronidazole)

Flagyl 200mg Tablet: Each film coated tablet contains 200mg of Metronidazole B.P.

Flagyl 400mg Tablet: Each film coated tablet contains 400mg of Metronidazole B.P.

Flagyl Suspension: Each 5ml of suspension contains Metronidazole Benzoate equivalent to 200mg of Metronidazole B.P.

Flagyl Infusion: Each 100ml bottle contains 500mg of Metronidazole B.P. (0.5%W/V).

Alternates

Gramex By Platinum Pharmaceuticals

Entamizole By Abbot

Klint By Sami Pharmaceuticals

Metodine By Searle Pharmaceuticals

Distribution Channel Direct Authorized distributors Whole Sellers.

Market Segmentation Pathogenic micro-organisms notably species

of Bacteroides Fusobacteria Clostridia Eubacteria Anaerobic cocci Gardnerella vaginalis

Target Marketing

The reason that pharmaceutical is fragmented market so we use target marketing techniques.

To those specialized physicians that are particularly practice in the segmented areas. General physician , surgeons etc.

SWOT AnalysisStrengths: Available in 4 variants Low Operating Overhead means High

Manageability Skills Research product. Market Leader State-of-the-art laboratory equipment and an

experienced research staff High Branding, they are at grass root level.

SWOT AnalysisWeaknesses: High-Risk Business Modeling means if a new

research is there in market that reject the on going research, the whole business model goes down.

Outdated medical equipment.

SWOT AnalysisOpportunities: Health-conscious consumers Recently published research Increased demand for pharmaceutical

products. Changes in Food and Drug Administration

standards.

SWOT AnalysisThreats: Increased government regulation Rivals A declining economy Increasing research and development (R&D)

costs A decrease in the global population. Political conditions

Marketing MixProduct (Pricing)

Flagyl has maximum market coverage pricing objectives.

Product 200mgPer Tablet

Price (PKR)

400mgPer Tablet

Price (PKR)

Injection (PKR)

Syrup100ml Price

(PKR)

Flagyl 1 1.5 78 32

Klint 1 1.5 N/A 35

Gramex N/A 2 N/A N/A

Metodine N/A 2 N/A N/A

Product Entamizole DS

(PKR)

Entamizole Tablet (PKR)

Entamizole Suspension

(PKR)

Entamizole

3 5 32

Marketing MixPlacement

Their Head office is at Karachi, at Korangi Industrial Area.

Marketing MixPlacement Sanofi-Aventis is present all over Pakistan comprising of 15 Distribution Centers at: Karachi Lahore Hyderabad Sukkur Bahawalpur Multan Quetta Faisalabad Sargodha Rawalpindi Gujranwala Peshawar Mardan Swat Gilgit

Regional Sales Office Sanofi-Aventis has 3 regional sales offices at: Karachi Lahore Rawalpindi

Marketing MixPlacement

Their Manufacturing and Industrial affairs are at Wah Cantt.

Marketing MixPositioning

Antiamoebic Anti-infective Generally Positioned use as anti-mycotic

(Antifungus) . Use for stomach disorder.

Promotional Strategy Medical Campaigns Chemist Trainings Doctors Presentation Promotions Samples Give-Aways Volume discounts (for distributors)

Differentiation High quality Packaging Market Leader Specific Composition of Metronidazole only Other Competitors like: Entamizole Tablet contains Diloxanide furoate 250mg

Metronidazole 200mg Entamizole DS contains Diloxanide furoate 500mg

Metronidazole 400mg Entamizole Suspension contains Diloxanide furoate

250mgMetronidazole benzoate 320mg equiv to metronidazole 200mg

Proven Results

Market ShareData By IMS

Product Value Unit Sales Growth Market Share

Flagyl 1428626606 21294917 0.74% 17.17%

Entamizole 427335442 9815194 0.22% 15.72%

Klint 47928616 906151 0.22% 301.64%

Metodine 18102115 480985 0.01% -89.14%

Gramex 9579406 74144 0.00% -13.03%

Value: Total Value in Pharmaceutical Market.Unit Sale: Number of Units Sold.Growth: Growth Rate in Pharmaceutical Market.Market Share: Total Share of Product in Pharmaceutical Market.

Recommendations Sustain better relationship with stake holders. Increase market coverage. Add more distribution channels. Sales promotions. Relationship with doctors.